3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Venous Thrombosis
1
Venous Thromboembolism
1
Neoplasms
1
Interventions
Dalteparin
8
apixaban
6
Rivaroxaban
6
Heparin, Low-Molecular-Weight
5
Tinzaparin
4
Enoxaparin
4
bemiparin
2
abelacimab
2
Warfarin
2
MAA868
2
Aspirin
2
reviparin
1
isoquercitrin
1
edoxaban
1
certoparin
1
betrixaban
1
argatroban
1
acarboxyprothrombin
1
Phenprocoumon
1
Nadroparin
1
N(4)-oleylcytosine arabinoside
1
Dabigatran
1
Acenocoumarol
1
AVE 5026
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Venous Thromboembolism
×
reviparin
×
Clear all
NCT01164046
2014-12-03
Longheva
University Medical Center Groningen
Phase 3
Terminated
56 enrolled